ID   DHX29_HUMAN             Reviewed;        1369 AA.
AC   Q7Z478; O75549; Q63HN0; Q63HN3; Q8IWW2; Q8N3A1; Q9UMH2;
DT   11-JUL-2006, integrated into UniProtKB/Swiss-Prot.
DT   11-JUL-2006, sequence version 2.
DT   28-JUN-2023, entry version 173.
DE   RecName: Full=ATP-dependent RNA helicase DHX29 {ECO:0000255|HAMAP-Rule:MF_03068};
DE            EC=3.6.4.13 {ECO:0000255|HAMAP-Rule:MF_03068};
DE   AltName: Full=DEAH box protein 29 {ECO:0000255|HAMAP-Rule:MF_03068};
DE   AltName: Full=Nucleic acid helicase DDXx;
GN   Name=DHX29 {ECO:0000255|HAMAP-Rule:MF_03068}; Synonyms=DDX29;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RA   Abdelhaleem M.M.;
RT   "Identification of a new member of the DDx subfamily of helicases.";
RL   Submitted (MAY-2001) to the EMBL/GenBank/DDBJ databases.
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA], AND VARIANT HIS-630.
RC   TISSUE=Brain;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 57-1369.
RC   TISSUE=Amygdala, Fetal kidney, and Testis;
RX   PubMed=17974005; DOI=10.1186/1471-2164-8-399;
RA   Bechtel S., Rosenfelder H., Duda A., Schmidt C.P., Ernst U.,
RA   Wellenreuther R., Mehrle A., Schuster C., Bahr A., Bloecker H., Heubner D.,
RA   Hoerlein A., Michel G., Wedler H., Koehrer K., Ottenwaelder B., Poustka A.,
RA   Wiemann S., Schupp I.;
RT   "The full-ORF clone resource of the German cDNA consortium.";
RL   BMC Genomics 8:399-399(2007).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 561-1369.
RA   Bassi M.T., Banfi S., Riboni M., Ballabio A., Borsani G.;
RL   Submitted (JUL-2000) to the EMBL/GenBank/DDBJ databases.
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 1119-1369.
RC   TISSUE=Brain;
RA   Yu W., Gibbs R.A.;
RL   Submitted (JUN-1998) to the EMBL/GenBank/DDBJ databases.
RN   [6]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-192 AND SER-200, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=16964243; DOI=10.1038/nbt1240;
RA   Beausoleil S.A., Villen J., Gerber S.A., Rush J., Gygi S.P.;
RT   "A probability-based approach for high-throughput protein phosphorylation
RT   analysis and site localization.";
RL   Nat. Biotechnol. 24:1285-1292(2006).
RN   [7]
RP   FUNCTION, RIBOSOME-BINDING, AND IDENTIFICATION BY MASS SPECTROMETRY.
RX   PubMed=19109895; DOI=10.1016/j.cell.2008.10.037;
RA   Pisareva V.P., Pisarev A.V., Komar A.A., Hellen C.U.T., Pestova T.V.;
RT   "Translation initiation on mammalian mRNAs with structured 5'UTRs requires
RT   DExH-box protein DHX29.";
RL   Cell 135:1237-1250(2008).
RN   [8]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-192 AND SER-200, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18669648; DOI=10.1073/pnas.0805139105;
RA   Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,
RA   Elledge S.J., Gygi S.P.;
RT   "A quantitative atlas of mitotic phosphorylation.";
RL   Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008).
RN   [9]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=19413330; DOI=10.1021/ac9004309;
RA   Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J., Mohammed S.;
RT   "Lys-N and trypsin cover complementary parts of the phosphoproteome in a
RT   refined SCX-based approach.";
RL   Anal. Chem. 81:4493-4501(2009).
RN   [10]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-71 AND SER-200, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=20068231; DOI=10.1126/scisignal.2000475;
RA   Olsen J.V., Vermeulen M., Santamaria A., Kumar C., Miller M.L.,
RA   Jensen L.J., Gnad F., Cox J., Jensen T.S., Nigg E.A., Brunak S., Mann M.;
RT   "Quantitative phosphoproteomics reveals widespread full phosphorylation
RT   site occupancy during mitosis.";
RL   Sci. Signal. 3:RA3-RA3(2010).
RN   [11]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P., Buerckstuemmer T.,
RA   Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [12]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-200, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21406692; DOI=10.1126/scisignal.2001570;
RA   Rigbolt K.T., Prokhorova T.A., Akimov V., Henningsen J., Johansen P.T.,
RA   Kratchmarova I., Kassem M., Mann M., Olsen J.V., Blagoev B.;
RT   "System-wide temporal characterization of the proteome and phosphoproteome
RT   of human embryonic stem cell differentiation.";
RL   Sci. Signal. 4:RS3-RS3(2011).
RN   [13]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-200, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma, and Erythroleukemia;
RX   PubMed=23186163; DOI=10.1021/pr300630k;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
RN   [14]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D., Wang L.,
RA   Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human liver
RT   phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
RN   [15]
RP   STRUCTURE BY ELECTRON MICROSCOPY (11.6 ANGSTROMS) IN COMPLEX WITH THE 43S
RP   PRE-INITIATION COMPLEX, FUNCTION, AND SUBUNIT.
RX   PubMed=23706745; DOI=10.1016/j.cell.2013.04.036;
RA   Hashem Y., des Georges A., Dhote V., Langlois R., Liao H.Y.,
RA   Grassucci R.A., Hellen C.U., Pestova T.V., Frank J.;
RT   "Structure of the mammalian ribosomal 43S preinitiation complex bound to
RT   the scanning factor DHX29.";
RL   Cell 153:1108-1119(2013).
CC   -!- FUNCTION: ATP-binding RNA helicase involved in translation initiation.
CC       Part of the 43S pre-initiation complex that is required for efficient
CC       initiation on mRNAs of higher eukaryotes with structured 5'-UTRs by
CC       promoting efficient NTPase-dependent 48S complex formation.
CC       Specifically binds to the 40S ribosome near the mRNA entrance. Does not
CC       possess a processive helicase activity. {ECO:0000255|HAMAP-
CC       Rule:MF_03068, ECO:0000269|PubMed:19109895,
CC       ECO:0000269|PubMed:23706745}.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=ATP + H2O = ADP + H(+) + phosphate; Xref=Rhea:RHEA:13065,
CC         ChEBI:CHEBI:15377, ChEBI:CHEBI:15378, ChEBI:CHEBI:30616,
CC         ChEBI:CHEBI:43474, ChEBI:CHEBI:456216; EC=3.6.4.13;
CC         Evidence={ECO:0000255|HAMAP-Rule:MF_03068};
CC   -!- SUBUNIT: Part of the 43S pre-initiation complex (PIC) that contains at
CC       least Met-tRNA, EIF1, EIF1A (EIF1AX or EIF1AY), EIF2S1, EIF2S2, EIF2S3,
CC       EIF3A, EIF3B, EIF3C, EIF3D, EIF3E, EIF3F, EIF3G, EIF3H, EIF3I, EIF3J,
CC       EIF3K, EIF3L, EIF3M, DHX29 and the 40S ribosomal subunit.
CC       {ECO:0000255|HAMAP-Rule:MF_03068, ECO:0000269|PubMed:23706745}.
CC   -!- SUBCELLULAR LOCATION: Cytoplasm {ECO:0000255|HAMAP-Rule:MF_03068}.
CC   -!- SIMILARITY: Belongs to the DEAD box helicase family. DEAH subfamily.
CC       {ECO:0000255|HAMAP-Rule:MF_03068}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AY036974; AAK64516.1; -; mRNA.
DR   EMBL; BC056219; AAH56219.1; -; mRNA.
DR   EMBL; AL834496; CAD39154.1; -; mRNA.
DR   EMBL; BX648101; CAH56172.1; -; mRNA.
DR   EMBL; BX648269; CAH56153.1; -; mRNA.
DR   EMBL; AL079292; CAB45191.1; -; mRNA.
DR   EMBL; AF070639; AAC25394.1; -; mRNA.
DR   CCDS; CCDS34158.1; -.
DR   RefSeq; NP_001332893.1; NM_001345964.1.
DR   RefSeq; NP_001332894.1; NM_001345965.1.
DR   RefSeq; NP_061903.2; NM_019030.3.
DR   AlphaFoldDB; Q7Z478; -.
DR   SMR; Q7Z478; -.
DR   BioGRID; 120001; 145.
DR   IntAct; Q7Z478; 30.
DR   MINT; Q7Z478; -.
DR   STRING; 9606.ENSP00000251636; -.
DR   BindingDB; Q7Z478; -.
DR   ChEMBL; CHEMBL4105909; -.
DR   GlyGen; Q7Z478; 1 site, 1 O-linked glycan (1 site).
DR   iPTMnet; Q7Z478; -.
DR   PhosphoSitePlus; Q7Z478; -.
DR   BioMuta; DHX29; -.
DR   DMDM; 110278938; -.
DR   EPD; Q7Z478; -.
DR   jPOST; Q7Z478; -.
DR   MassIVE; Q7Z478; -.
DR   MaxQB; Q7Z478; -.
DR   PaxDb; Q7Z478; -.
DR   PeptideAtlas; Q7Z478; -.
DR   ProteomicsDB; 69161; -.
DR   Antibodypedia; 11081; 113 antibodies from 22 providers.
DR   DNASU; 54505; -.
DR   Ensembl; ENST00000251636.10; ENSP00000251636.5; ENSG00000067248.11.
DR   GeneID; 54505; -.
DR   KEGG; hsa:54505; -.
DR   MANE-Select; ENST00000251636.10; ENSP00000251636.5; NM_019030.4; NP_061903.2.
DR   UCSC; uc003jpx.4; human.
DR   AGR; HGNC:15815; -.
DR   CTD; 54505; -.
DR   DisGeNET; 54505; -.
DR   GeneCards; DHX29; -.
DR   HGNC; HGNC:15815; DHX29.
DR   HPA; ENSG00000067248; Low tissue specificity.
DR   MIM; 612720; gene.
DR   neXtProt; NX_Q7Z478; -.
DR   OpenTargets; ENSG00000067248; -.
DR   PharmGKB; PA27215; -.
DR   VEuPathDB; HostDB:ENSG00000067248; -.
DR   eggNOG; KOG0920; Eukaryota.
DR   GeneTree; ENSGT00940000157286; -.
DR   HOGENOM; CLU_001832_1_4_1; -.
DR   InParanoid; Q7Z478; -.
DR   OMA; SWFANMS; -.
DR   OrthoDB; 1095660at2759; -.
DR   PhylomeDB; Q7Z478; -.
DR   TreeFam; TF324744; -.
DR   PathwayCommons; Q7Z478; -.
DR   SignaLink; Q7Z478; -.
DR   BioGRID-ORCS; 54505; 122 hits in 1178 CRISPR screens.
DR   ChiTaRS; DHX29; human.
DR   GenomeRNAi; 54505; -.
DR   Pharos; Q7Z478; Tbio.
DR   PRO; PR:Q7Z478; -.
DR   Proteomes; UP000005640; Chromosome 5.
DR   RNAct; Q7Z478; protein.
DR   Bgee; ENSG00000067248; Expressed in esophagus squamous epithelium and 212 other tissues.
DR   ExpressionAtlas; Q7Z478; baseline and differential.
DR   Genevisible; Q7Z478; HS.
DR   GO; GO:0022627; C:cytosolic small ribosomal subunit; IDA:CACAO.
DR   GO; GO:0016282; C:eukaryotic 43S preinitiation complex; IDA:UniProtKB.
DR   GO; GO:0005524; F:ATP binding; IEA:UniProtKB-UniRule.
DR   GO; GO:0016887; F:ATP hydrolysis activity; IEA:RHEA.
DR   GO; GO:0045296; F:cadherin binding; HDA:BHF-UCL.
DR   GO; GO:0004386; F:helicase activity; IBA:GO_Central.
DR   GO; GO:0017111; F:ribonucleoside triphosphate phosphatase activity; IMP:CACAO.
DR   GO; GO:0043024; F:ribosomal small subunit binding; IDA:UniProtKB.
DR   GO; GO:0003723; F:RNA binding; HDA:UniProtKB.
DR   GO; GO:0003724; F:RNA helicase activity; IEA:UniProtKB-UniRule.
DR   GO; GO:0008494; F:translation activator activity; IMP:CACAO.
DR   GO; GO:0003743; F:translation initiation factor activity; IEA:UniProtKB-KW.
DR   GO; GO:0001731; P:formation of translation preinitiation complex; IMP:CACAO.
DR   GO; GO:0045948; P:positive regulation of translational initiation; IEA:UniProtKB-UniRule.
DR   GO; GO:0042255; P:ribosome assembly; IMP:CACAO.
DR   CDD; cd17975; DEXHc_DHX29; 1.
DR   CDD; cd18791; SF2_C_RHA; 1.
DR   Gene3D; 1.20.120.1080; -; 1.
DR   Gene3D; 3.40.50.300; P-loop containing nucleotide triphosphate hydrolases; 2.
DR   HAMAP; MF_03068; DHX29; 1.
DR   InterPro; IPR011709; DEAD-box_helicase_OB_fold.
DR   InterPro; IPR011545; DEAD/DEAH_box_helicase_dom.
DR   InterPro; IPR034730; DHX29.
DR   InterPro; IPR002464; DNA/RNA_helicase_DEAH_CS.
DR   InterPro; IPR007502; Helicase-assoc_dom.
DR   InterPro; IPR014001; Helicase_ATP-bd.
DR   InterPro; IPR001650; Helicase_C.
DR   InterPro; IPR027417; P-loop_NTPase.
DR   PANTHER; PTHR18934; ATP-DEPENDENT RNA HELICASE; 1.
DR   PANTHER; PTHR18934:SF145; ATP-DEPENDENT RNA HELICASE DHX29; 1.
DR   Pfam; PF00270; DEAD; 1.
DR   Pfam; PF04408; HA2; 1.
DR   Pfam; PF00271; Helicase_C; 1.
DR   Pfam; PF07717; OB_NTP_bind; 1.
DR   SMART; SM00487; DEXDc; 1.
DR   SMART; SM00847; HA2; 1.
DR   SMART; SM00490; HELICc; 1.
DR   SUPFAM; SSF52540; P-loop containing nucleoside triphosphate hydrolases; 1.
DR   PROSITE; PS00690; DEAH_ATP_HELICASE; 1.
DR   PROSITE; PS51192; HELICASE_ATP_BIND_1; 1.
DR   PROSITE; PS51194; HELICASE_CTER; 1.
PE   1: Evidence at protein level;
KW   ATP-binding; Coiled coil; Cytoplasm; Helicase; Hydrolase;
KW   Initiation factor; Nucleotide-binding; Phosphoprotein;
KW   Protein biosynthesis; Reference proteome.
FT   CHAIN           1..1369
FT                   /note="ATP-dependent RNA helicase DHX29"
FT                   /id="PRO_0000245535"
FT   DOMAIN          582..755
FT                   /note="Helicase ATP-binding"
FT                   /evidence="ECO:0000255|HAMAP-Rule:MF_03068"
FT   DOMAIN          849..1026
FT                   /note="Helicase C-terminal"
FT                   /evidence="ECO:0000255|HAMAP-Rule:MF_03068"
FT   REGION          27..75
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          176..226
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          502..526
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COILED          222..256
FT                   /evidence="ECO:0000255|HAMAP-Rule:MF_03068"
FT   COILED          283..310
FT                   /evidence="ECO:0000255|HAMAP-Rule:MF_03068"
FT   COILED          492..519
FT                   /evidence="ECO:0000255|HAMAP-Rule:MF_03068"
FT   MOTIF           702..705
FT                   /note="DEAH box"
FT                   /evidence="ECO:0000255|HAMAP-Rule:MF_03068"
FT   COMPBIAS        186..205
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        208..226
FT                   /note="Basic and acidic residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   BINDING         595..602
FT                   /ligand="ATP"
FT                   /ligand_id="ChEBI:CHEBI:30616"
FT                   /evidence="ECO:0000255|HAMAP-Rule:MF_03068"
FT   MOD_RES         71
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:20068231"
FT   MOD_RES         192
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:16964243,
FT                   ECO:0007744|PubMed:18669648"
FT   MOD_RES         200
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:16964243,
FT                   ECO:0007744|PubMed:18669648, ECO:0007744|PubMed:20068231,
FT                   ECO:0007744|PubMed:21406692, ECO:0007744|PubMed:23186163"
FT   VARIANT         309
FT                   /note="D -> A (in dbSNP:rs35874395)"
FT                   /id="VAR_052180"
FT   VARIANT         630
FT                   /note="P -> H (in dbSNP:rs17854904)"
FT                   /evidence="ECO:0000269|PubMed:15489334"
FT                   /id="VAR_026985"
FT   CONFLICT        121
FT                   /note="A -> D (in Ref. 3; CAH56172)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        185
FT                   /note="K -> E (in Ref. 3; CAH56153)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        356
FT                   /note="D -> G (in Ref. 1; AAK64516)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        885
FT                   /note="D -> G (in Ref. 3; CAH56172)"
FT                   /evidence="ECO:0000305"
SQ   SEQUENCE   1369 AA;  155236 MW;  F720A77D224C7F59 CRC64;
     MGGKNKKHKA PAAAVVRAAV SASRAKSAEA GIAGEAQSKK PVSRPATAAA AAAGSREPRV
     KQGPKIYSFN STNDSSGPAN LDKSILKVVI NNKLEQRIIG VINEHKKQNN DKGMISGRLT
     AKKLQDLYMA LQAFSFKTKD IEDAMTNTLL YGGDLHSALD WLCLNLSDDA LPEGFSQEFE
     EQQPKSRPKF QSPQIQATIS PPLQPKTKTY EEDPKSKPKK EEKNMEVNMK EWILRYAEQQ
     NEEEKNENSK SLEEEEKFDP NERYLHLAAK LLDAKEQAAT FKLEKNKQGQ KEAQEKIRKF
     QREMETLEDH PVFNPAMKIS HQQNERKKPP VATEGESALN FNLFEKSAAA TEEEKDKKKE
     PHDVRNFDYT ARSWTGKSPK QFLIDWVRKN LPKSPNPSFE KVPVGRYWKC RVRVIKSEDD
     VLVVCPTILT EDGMQAQHLG ATLALYRLVK GQSVHQLLPP TYRDVWLEWS DAEKKREELN
     KMETNKPRDL FIAKLLNKLK QQQQQQQQHS ENKRENSEDP EESWENLVSD EDFSALSLES
     ANVEDLEPVR NLFRKLQSTP KYQKLLKERQ QLPVFKHRDS IVETLKRHRV VVVAGETGSG
     KSTQVPHFLL EDLLLNEWEA SKCNIVCTQP RRISAVSLAN RVCDELGCEN GPGGRNSLCG
     YQIRMESRAC ESTRLLYCTT GVLLRKLQED GLLSNVSHVI VDEVHERSVQ SDFLLIILKE
     ILQKRSDLHL ILMSATVDSE KFSTYFTHCP ILRISGRSYP VEVFHLEDII EETGFVLEKD
     SEYCQKFLEE EEEVTINVTS KAGGIKKYQE YIPVQTGAHA DLNPFYQKYS SRTQHAILYM
     NPHKINLDLI LELLAYLDKS PQFRNIEGAV LIFLPGLAHI QQLYDLLSND RRFYSERYKV
     IALHSILSTQ DQAAAFTLPP PGVRKIVLAT NIAETGITIP DVVFVIDTGR TKENKYHESS
     QMSSLVETFV SKASALQRQG RAGRVRDGFC FRMYTRERFE GFMDYSVPEI LRVPLEELCL
     HIMKCNLGSP EDFLSKALDP PQLQVISNAM NLLRKIGACE LNEPKLTPLG QHLAALPVNV
     KIGKMLIFGA IFGCLDPVAT LAAVMTEKSP FTTPIGRKDE ADLAKSALAM ADSDHLTIYN
     AYLGWKKARQ EGGYRSEITY CRRNFLNRTS LLTLEDVKQE LIKLVKAAGF SSSTTSTSWE
     GNRASQTLSF QEIALLKAVL VAGLYDNVGK IIYTKSVDVT EKLACIVETA QGKAQVHPSS
     VNRDLQTHGW LLYQEKIRYA RVYLRETTLI TPFPVLLFGG DIEVQHRERL LSIDGWIYFQ
     APVKIAVIFK QLRVLIDSVL RKKLENPKMS LENDKILQII TELIKTENN
//
